[
  {
    "ts": "2026-02-03T03:04:43+00:00",
    "headline": "Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect",
    "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) will be announcing earnings results this Wednesday before market open. Here’s what to look for.",
    "url": "https://finance.yahoo.com/news/bio-techne-tech-reports-earnings-030443795.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "7803a18b-a5a5-3752-a5bc-be3a127d34cd",
      "content": {
        "id": "7803a18b-a5a5-3752-a5bc-be3a127d34cd",
        "contentType": "STORY",
        "title": "Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect",
        "description": "",
        "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) will be announcing earnings results this Wednesday before market open. Here’s what to look for.",
        "pubDate": "2026-02-03T03:04:43Z",
        "displayTime": "2026-02-03T03:04:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/4439f8d76fe0b091f617ad2a71c09aaf",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "TECH Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LYiy8pdxjjKKPO37OJyQAg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/4439f8d76fe0b091f617ad2a71c09aaf.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/D4gEv3cExkoBPyh482djbA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/4439f8d76fe0b091f617ad2a71c09aaf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-tech-reports-earnings-030443795.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-tech-reports-earnings-030443795.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T02:11:13+00:00",
    "headline": "A Look At Bio Techne (TECH) Valuation After Cultrex Synthetic Hydrogel Launch",
    "summary": "Bio-Techne (TECH) shares are back in focus after the company introduced Cultrex Synthetic Hydrogel, a fully defined extracellular matrix designed to improve reproducibility, scalability, and regulatory alignment in 3D stem cell and organoid research. See our latest analysis for Bio-Techne. These product launches in organoid and neurology research have arrived during a period where the share price has a 30 day return of 9.39% and a year to date share price return of 9.39%, while the 1 year...",
    "url": "https://finance.yahoo.com/news/look-bio-techne-tech-valuation-021113360.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "aa52c450-8706-3fc2-9473-3061add1ebe4",
      "content": {
        "id": "aa52c450-8706-3fc2-9473-3061add1ebe4",
        "contentType": "STORY",
        "title": "A Look At Bio Techne (TECH) Valuation After Cultrex Synthetic Hydrogel Launch",
        "description": "",
        "summary": "Bio-Techne (TECH) shares are back in focus after the company introduced Cultrex Synthetic Hydrogel, a fully defined extracellular matrix designed to improve reproducibility, scalability, and regulatory alignment in 3D stem cell and organoid research. See our latest analysis for Bio-Techne. These product launches in organoid and neurology research have arrived during a period where the share price has a 30 day return of 9.39% and a year to date share price return of 9.39%, while the 1 year...",
        "pubDate": "2026-02-03T02:11:13Z",
        "displayTime": "2026-02-03T02:11:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Ih9Jyeb4E8RAOq22ZtFHA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5jgPUxQrxmcesBmGBKgkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/look-bio-techne-tech-valuation-021113360.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/look-bio-techne-tech-valuation-021113360.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T14:15:39+00:00",
    "headline": "Is Bio-Techne (TECH) Fairly Priced After Recent Share Price Rebound?",
    "summary": "If you are wondering whether Bio-Techne at around US$65 per share offers good value today, you are not alone. This article focuses squarely on what that price might mean for long term investors. The stock has had a mixed recent run, with a 9.4% gain over the past month, a 9.4% return year to date, but a 1 year return of 8.9% decline and a 5 year return of 31.8% decline that may leave some holders questioning what comes next. Recent attention on Bio-Techne has been shaped by ongoing interest...",
    "url": "https://finance.yahoo.com/news/bio-techne-tech-fairly-priced-141539470.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "96ecae5f-6435-376d-8aac-0f8e5ae9f6f4",
      "content": {
        "id": "96ecae5f-6435-376d-8aac-0f8e5ae9f6f4",
        "contentType": "STORY",
        "title": "Is Bio-Techne (TECH) Fairly Priced After Recent Share Price Rebound?",
        "description": "",
        "summary": "If you are wondering whether Bio-Techne at around US$65 per share offers good value today, you are not alone. This article focuses squarely on what that price might mean for long term investors. The stock has had a mixed recent run, with a 9.4% gain over the past month, a 9.4% return year to date, but a 1 year return of 8.9% decline and a 5 year return of 31.8% decline that may leave some holders questioning what comes next. Recent attention on Bio-Techne has been shaped by ongoing interest...",
        "pubDate": "2026-02-03T14:15:39Z",
        "displayTime": "2026-02-03T14:15:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Ih9Jyeb4E8RAOq22ZtFHA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5jgPUxQrxmcesBmGBKgkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-tech-fairly-priced-141539470.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-tech-fairly-priced-141539470.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]